Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03733041 · ClinicalTrials.gov registry record · NA

Neuromodulation for Exercise Adherence

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT03733041: Completed NA study, sponsored by VA Office of Research and Development.

NCT03733041 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03733041, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

Lack of adherence to an exercise program is a major problem for older Veterans. Several fall prevention programs fail in the home setting due to lack of adherence. Exercise adherence is dependent on brain function among other factors. Magnetic stimulation of the front part of the brain improves brain function necessary for planning and following-through. The investigators propose a three-phase study in 106 sedentary older Veterans. Everyone will be trained on use of the exergames, Nintendo Wii-Fit, that the investigators' team has found beneficial in improving balance and gait. They will be asked to exercise using Wii-Fit at home for 45 minutes daily five days/week for 12-weeks. Those that exercise less than recommended dose and those that exercise adequately but have low executive function will receive either real or sham magnetic stimulation to the front part of their brain over ten sessions paired with exercise training. All subjects will further complete 24-weeks of Wii-Fit home exercises. Adherence, executive function, balance and gait, self-efficacy, delay discounting, and falls will be measured periodically.

Interventions

  • DEVICE Sham treatment
  • DEVICE Repetitive Transcranial Magnetic Stimulator
  • DEVICE Nintendo Wii-Fit exercises

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2019-04-01
Est. Completion 2025-05-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03733041

The ClinicalTrials.gov registry entry for NCT03733041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Sham treatment is the first listed.

NCT03733041 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03733041 about?

NCT03733041 is a clinical study titled "Neuromodulation for Exercise Adherence". Lack of adherence to an exercise program is a major problem for older Veterans. Several fall prevention programs fail in the home setting due to lack of adherence. Exercise adherence is dependent on brain function among other factors. Magnetic stimulation of the front part of the brain improves brai...

What is the current status of trial NCT03733041?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2019-04-01. Estimated completion is 2025-05-31.

What interventions are being tested in trial NCT03733041?

The interventions under investigation include: Sham treatment (DEVICE), Repetitive Transcranial Magnetic Stimulator (DEVICE), Nintendo Wii-Fit exercises (DEVICE).

Who is sponsoring clinical trial NCT03733041?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.